[Hepatic resection and hepatic arterial chemoembolization for primary liver carcinoma]
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|March 4, 2000
Abstract:
Three hundreds of primary liver carcinoma (PLC) were subjected to hepatic resection and hepatic chemoembolization (HACE). Among them, hepatic resetion was performed in 106 cases, and HACE in 194. The two-stage operation after HACE was performed in 23 cases. Hepatitis B antigen was positive in 69.8%. PLC with cirrhosis accounted for 81.6%. The effect of hepatic resection was superior to HACE. The cause of early local recurrence after HACE can be a valuable therapy in the hepervascular PLC. However, HACE should be unsuitable for ischemic PLC. Quantitative estimation of hepatic resection of PLC with cirrhosis was dependent on 5 parameters (ALT, serum bilirubin, PT and R15TCG), and morphological changes of cirrhotic liver.


